Global Migraine Drugs Market Professional Survey Report 2016

Publisher Name :
Date: 07-Jun-2016
No. of pages: 109
Inquire Before Buying

This report mainly covers the following

Product types including

Anti-inflammatory Painkillers

Antimigraine Drugs

Antisickness Medicines

Others

The segment applications including

Hospital use

Clinic use

Household

Segment regions including (the separated region report can also be offered)

North America

Europe

Japan

China

Southeast Asia

India

The players list (Partly, Players you are interested in can also be added)

Allergan

Endo International

GlaxoSmithKline

Impax

Pfizer

Abbott

Impax Laboratories

Johnson & Johnson

Boehringer Ingelheim

Eli Lilly

IntelGenx Technologies

Nautilus

RedHill Biopharma

Eisai

Bayer

Luitpold Pharmaceuticals

Merck

TG Therapeutics

With 18 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Global Migraine Drugs Market Professional Survey Report 2016

Table of Contents
1 Industry Overview of Migraine Drugs
1.1 Definition and Specifications of Migraine Drugs
1.1.1 Definition of Migraine Drugs
1.1.2 Specifications of Migraine Drugs
1.2 Classification of Migraine Drugs
1.2.1 Anti-inflammatory Painkillers
1.2.2 Antimigraine Drugs
1.2.3 Antisickness Medicines
1.2.4 Others
1.3 Applications of Migraine Drugs
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Household
1.4 Industry Chain Structure of Migraine Drugs
1.5 Industry Overview and Major Regions Status of Migraine Drugs
1.5.1 Industry Overview of Migraine Drugs
1.5.2 Global Major Regions Status of Migraine Drugs
1.6 Industry Policy Analysis of Migraine Drugs
1.7 Industry News Analysis of Migraine Drugs
2 Manufacturing Cost Structure Analysis of Migraine Drugs
2.1 Raw Material Suppliers and Price Analysis of Migraine Drugs
2.2 Equipment Suppliers and Price Analysis of Migraine Drugs
2.3 Labor Cost Analysis of Migraine Drugs
2.4 Other Costs Analysis of Migraine Drugs
2.5 Manufacturing Cost Structure Analysis of Migraine Drugs
2.6 Manufacturing Process Analysis of Migraine Drugs
3 Technical Data and Manufacturing Plants Analysis of Migraine Drugs
3.1 Capacity and Commercial Production Date of Global Migraine Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Migraine Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Migraine Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Migraine Drugs Major Manufacturers in 2015
4 Global Migraine Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Migraine Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Migraine Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Migraine Drugs Sales and Growth Rate Analysis
4.3.2 2015 Migraine Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Migraine Drugs Sales Price
4.4.2 2015 Migraine Drugs Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Migraine Drugs Gross Margin
4.5.2 2015 Migraine Drugs Gross Margin Analysis (Company Segment)
5 Migraine Drugs Regional Market Analysis
5.1 North America Migraine Drugs Market Analysis
5.1.1 North America Migraine Drugs Market Overview
5.1.2 North America 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Migraine Drugs Sales Price Analysis
5.1.4 North America 2015 Migraine Drugs Market Share Analysis
5.2 Europe Migraine Drugs Market Analysis
5.2.1 Europe Migraine Drugs Market Overview
5.2.2 Europe 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Migraine Drugs Sales Price Analysis
5.2.4 Europe 2015 Migraine Drugs Market Share Analysis
5.3 Japan Migraine Drugs Market Analysis
5.3.1 Japan Migraine Drugs Market Overview
5.3.2 Japan 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Migraine Drugs Sales Price Analysis
5.3.4 Japan 2015 Migraine Drugs Market Share Analysis
5.4 China Migraine Drugs Market Analysis
5.4.1 China Migraine Drugs Market Overview
5.4.2 China 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Migraine Drugs Sales Price Analysis
5.4.4 China 2015 Migraine Drugs Market Share Analysis
5.5 Southeast Asia Migraine Drugs Market Analysis
5.5.1 Southeast Asia Migraine Drugs Market Overview
5.5.2 Southeast Asia 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Migraine Drugs Sales Price Analysis
5.5.4 Southeast Asia 2015 Migraine Drugs Market Share Analysis
5.6 India Migraine Drugs Market Analysis
5.6.1 India Migraine Drugs Market Overview
5.6.2 India 2011-2016E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Migraine Drugs Sales Price Analysis
5.6.4 India 2015 Migraine Drugs Market Share Analysis
6 Global 2011-2016E Migraine Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Migraine Drugs Sales by Type
6.2 Different Types Migraine Drugs Product Interview Price Analysis
6.3 Different Types Migraine Drugs Product Driving Factors Analysis
6.3.1 Anti-inflammatory Painkillers Migraine Drugs Growth Driving Factor Analysis
6.3.2 Antimigraine Drugs Migraine Drugs Growth Driving Factor Analysis
6.3.3 Antisickness Medicines Migraine Drugs Growth Driving Factor Analysis
6.3.4 Others Migraine Drugs Growth Driving Factor Analysis
7 Global 2011-2016E Migraine Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Migraine Drugs Growth Driving Factor Analysis
7.3.2 Clinic use Migraine Drugs Growth Driving Factor Analysis
7.3.3 Household Migraine Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Migraine Drugs
8.1 Allergan
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Allergan 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Allergan 2015 Migraine Drugs Business Region Distribution Analysis
8.2 Endo International
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Endo International 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Endo International 2015 Migraine Drugs Business Region Distribution Analysis
8.3 GlaxoSmithKline
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 GlaxoSmithKline 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 GlaxoSmithKline 2015 Migraine Drugs Business Region Distribution Analysis
8.4 Impax
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Impax 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Impax 2015 Migraine Drugs Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Pfizer 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2015 Migraine Drugs Business Region Distribution Analysis
8.6 Abbott
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Abbott 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Abbott 2015 Migraine Drugs Business Region Distribution Analysis
8.7 Impax Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Impax Laboratories 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Impax Laboratories 2015 Migraine Drugs Business Region Distribution Analysis
8.8 Johnson & Johnson
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Johnson & Johnson 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Johnson & Johnson 2015 Migraine Drugs Business Region Distribution Analysis
8.9 Boehringer Ingelheim
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Boehringer Ingelheim 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Boehringer Ingelheim 2015 Migraine Drugs Business Region Distribution Analysis
8.10 Eli Lilly
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Eli Lilly 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Eli Lilly 2015 Migraine Drugs Business Region Distribution Analysis
8.11 IntelGenx Technologies
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 IntelGenx Technologies 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 IntelGenx Technologies 2015 Migraine Drugs Business Region Distribution Analysis
8.12 Nautilus
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Nautilus 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Nautilus 2015 Migraine Drugs Business Region Distribution Analysis
8.13 RedHill Biopharma
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 RedHill Biopharma 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 RedHill Biopharma 2015 Migraine Drugs Business Region Distribution Analysis
8.14 Eisai
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Eisai 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Eisai 2015 Migraine Drugs Business Region Distribution Analysis
8.15 Bayer
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Bayer 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Bayer 2015 Migraine Drugs Business Region Distribution Analysis
8.16 Luitpold Pharmaceuticals
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Luitpold Pharmaceuticals 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Luitpold Pharmaceuticals 2015 Migraine Drugs Business Region Distribution Analysis
8.17 Merck
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Merck 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Merck 2015 Migraine Drugs Business Region Distribution Analysis
8.18 TG Therapeutics
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 TG Therapeutics 2015 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 TG Therapeutics 2015 Migraine Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Migraine Drugs Consumption Forecast
9.2.2 Europe 2016-2021 Migraine Drugs Consumption Forecast
9.2.3 Japan 2016-2021 Migraine Drugs Consumption Forecast
9.2.4 China 2016-2021 Migraine Drugs Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Migraine Drugs Consumption Forecast
9.2.6 India 2016-2021 Migraine Drugs Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Migraine Drugs Marketing Model Analysis
10.1 Migraine Drugs Regional Marketing Model Analysis
10.2 Migraine Drugs International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Migraine Drugs by Regions
10.4 Migraine Drugs Supply Chain Analysis
11 Consumers Analysis of Migraine Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 New Project Investment Feasibility Analysis of Migraine Drugs
12.1 New Project SWOT Analysis of Migraine Drugs
12.2 New Project Investment Feasibility Analysis of Migraine Drugs
13 Conclusion of the Global Migraine Drugs Market Professional Survey Report 2016
  • Global Migraine Drugs Sales Market Report 2017
    Published: 13-Nov-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Migraine Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan ......
  • Global Neuromyelitis Optica Drug Sales Market Report 2017
    Published: 13-Nov-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the global Neuromyelitis Optica Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Neuromyelitis Optica Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Neuromyelitis Optica Drug Market Research Report 2017
    Published: 31-Oct-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Neuromyelitis Optica Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neuromyelitis Optica Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • Global Migraine Drugs Market Research Report 2017
    Published: 31-Oct-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Migraine Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Edaravone Market Professional Survey Report 2017
    Published: 25-Oct-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Edaravone in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharma......
  • EpiCast Report: Epilepsy - Epidemiology Forecast to 2026
    Published: 12-Oct-2017        Price: US 3995 Onwards        Pages: 45
    EpiCast Report: Epilepsy - Epidemiology Forecast to 2026 Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain (WHO, 2017). It is one of the most common neurological conditions globally (WHO, 2017). Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered a seizure and is referred to a specialist......
  • Global and Regional Neuromyelitis Optica Drug Market Research Report 2017
    Published: 04-Oct-2017        Price: US 3500 Onwards        Pages: 122
    Summary Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve ......
  • United States Edaravone Market Report 2017
    Published: 03-Oct-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Edaravone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Edarav......
  • Global Edaravone Sales Market Report 2017
    Published: 28-Sep-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Edaravone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Edaravone for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southea......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs